All Pharma News
Dragonfly, Merck Collaborate On DF9001 TriNKET Plus KEYTRUDA

Dragonfly, Merck Collaborate On DF9001 TriNKET Plus KEYTRUDA
PR NEWSWIRE
21 May 2024
Share Share
Dragonfly, Merck Partner to Evaluate DF9001 in Combination with Keytruda

Dragonfly, Merck Partner to Evaluate DF9001 in Combination with Keytruda
CONTRACT PHARMA
21 May 2024
Share Share
Dragonfly has Received Payment Following Dosing of Patient in DF4101/ABBV-303

Dragonfly has Received Payment Following Dosing of Patient in DF4101/ABBV-303
PR NEWSWIRE
05 Mar 2024
Share Share
Dragonfly Announces Collaboration Exploring Combinations of DF1001 with Trodelvy

Dragonfly Announces Collaboration Exploring Combinations of DF1001 with Trodelvy
PR NEWSWIRE
15 Feb 2024
Share Share
Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy

Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy
PR NEWSWIRE
05 Dec 2023
Share Share
Dragonfly Announces the Presentation of Phase 1 DF1001 TriNKET Results at ASCO

Dragonfly Announces the Presentation of Phase 1 DF1001 TriNKET Results at ASCO
PR NEWSWIRE
05 Jun 2023
Share Share
Dragonfly Therapeutics Expands Clinical Leadership Team

Dragonfly Therapeutics Expands Clinical Leadership Team
CONTRACT PHARMA
02 Jun 2023
Share Share
Dragonfly to Present Phase 1 DF1001 Monotherapy Dose Escalation Results

Dragonfly to Present Phase 1 DF1001 Monotherapy Dose Escalation Results
PR NEWSWIRE
02 Jun 2023
Share Share
Dragonfly Therapeutics Announces the Publication of Preclinical Data DF6002

Dragonfly Therapeutics Announces the Publication of Preclinical Data DF6002
PR NEWSWIRE
17 Apr 2023
Share Share
BMS returns $475M IL-12 oncology asset to Dragonfly`s pond

BMS returns $475M IL-12 oncology asset to Dragonfly`s pond
Gabrielle Masson FIERCE BIOTECH
07 Feb 2023
Share Share